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Shigeki Inui1*, Ayako Mori2, Masayuki Ito3, Sayuri Hyodo3 and Satoshi Itami1Abstract
Background: Conspicuous facial pores are therapeutic targets for cosmeceuticals. Here we examine the effect of
topical fullerene on conspicuous facial pores using a new image analyser called the VISIA® system. Ten healthy
Japanese females participated in this study, and they received applications of 1% fullerene lotion to the face twice
a day for 8 weeks.
Findings: Fullerene lotion significantly decreased conspicuous pores by 17.6% (p < 0.05, Wilcoxon signed-rank test)
after an 8-week treatment. A self-administered questionnaire indicated that this reduction achieved cosmetically
appreciable effects. In addition, to investigate the mechanism of effect of fullerene, we examined its effect on
UVB-induced prostaglandin E2 (PGE2) production in reconstructed human epidermis (RhE). The results showed that
irradiation of RhE with 1000 mJ/cm2 increased PGE2 production by 62.3% (p < 0.05, Mann-Whitney U-test) and the
addition of 28 μM fullerene significantly suppressed the UVB-induced PGE2 production by 18.3% (p < 0.05).
Conclusions: Fullerene lotion significantly decreases conspicuous facial pores after an 8-week treatment possibly
through the suppression of PGE2 production in the epidermis.
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Conspicuous facial pores are therapeutic targets for cosme-
ceuticals. Previously it has been reported that the topical
vitamin C derivative ascorbyl 2-phosphate 6-palmitate
(APPS) decreased conspicuous facial pores [1]. Here we
examine the effect of topical fullerene on conspicuous facial
pores using the new image analszer called the VISIA® sys-
tem (Canfield Scientific Inc., Fairfield, NJ).
Methods
Ten healthy Japanese females participated in this study be-
tween January and June of 2013 at Clinic Mori (Minato-ku,
Tokyo). Age range of participants was from 39 to 70 years
and the mean age was 46 years. After an informed consent
was obtained, 1% fullerene lotion (Radical Sponge® 1.0%, 2-
phenoxyethanol 0.5%, glycerine 5.0%, 1,3-butylene glycol
5.0%, essential oil as needed, water q.s. to 100%) was* Correspondence: inui@r-derma.med.osaka-u.ac.jp
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unless otherwise stated.applied on the face twice a day for 8 weeks. The subjects
were not permitted to use sunscreen products. However,
they were allowed to use ordinary cosmetics but not medi-
cinal cosmetics. The high-resolution analysing system
VISIA-CR (Canfield, Fairfield, NJ) was used for computer
analysis to precisely measure conspicuous pores through
analysis scripts [2]. The photographs from VISIA-CR were
analysed by a pores analysis algorithm in Vaestro image
analysis toolkit, v 2.0 (Canfield, Fairfield, NJ) and subse-
quently the visible conspicuous facial pores were quantita-
tively measured. The analysis was carried out separately on
the right and left sides of the face and the results were com-
bined to get the total pore count. In principle, the pores
were recognised as circular areas darker than the surround-
ing skin tone and much smaller than skin spots. This study
was approved by the institutional ethics committee. An
informed consent was obtained from all patients before
enrolment in the study. To examine the effect of fullerene
on UVB-induced prostaglandin E2 (PGE2) production in
reconstructed human epidermis (RhE) LabCyte EPI-
MODEL24 (Japan Tissue Engineering Co. Ltd, Gamagori,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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of the kit on the 24-well plate for 1 hour at 37°C in a hu-
midified atmosphere containing 5% CO2. Then, 2.8 or 28
μM water-soluble polyvinylpyrrolidone (PVP)-wrapped ful-
lerene or a mock solution (1% PVP in PBS) was added.
After incubation for 1 hour, the cultures were irradiated
with 1000 mJ/cm2 UVB. Thirty minutes later, the medium
was aspirated and the cells were washed three times with
PBS. The cultures were kept in the fresh medium for 6
hours and the conditioned medium was finally subjected to
PGE2 ELISA (PGE2 EIA Monoclonal Kit, Cayman Chem-
ical Company, Michigan). A statistical analysis was per-
formed using Wilcoxon signed-rank test or Mann-Whitney
U-test. A difference with a p value of <0.05 was considered
significant.
Results and discussion
The mean number of conspicuous facial pores before and
after the fullerene lotion treatment is shown in Figure 1a.
The fullerene lotion significantly decreased the conspicuous
pores by 17.6% (p < 0.05, Wilcoxon signed-rank test) after
an 8-week treatment. Because this reduction seemed
moderately significant to establish cosmetic efficiency,
we administered a self-administered questionnaire, which
inquired regarding whether participants felt the effect of
the tested lotion on opening and pigmentation of pores, fa-
cial skin texture and the general condition of facial skin.
Among the 10 subjects enrolled, 7 felt an improvement of
texture and general condition of facial skin, and 6 felt that
there was improvement of the opening and pigmentation

























Figure 1 Effect of fullerene on conspicuous facial pores. (a) Reduction
The graph shows the mean ± standard deviation (n = 10). *p < 0.05, Wilcoxo
by VISIA® in the representative case (43-year-old female) before (upper pan
The number of conspicuous pores has decreased from 170 to 103. (c) Usin
observed in the same case.appreciable cosmetic effect. The representative case is
shown in Figure 1b, which demonstrates a reduction in the
conspicuous pores on the cheek. Using dermoscopy, the re-
gression of the conspicuous pores (triangles) was observed
in the same case (Figure 1c). It has been previously re-
ported that skin pigmentation can be classified into three
main patterns, i.e., spotty, globular and elongated types,
using a video camera equipped with an UV-emitting unit
[3]. Moreover, the spotty type corresponds to a perifollicu-
lar pattern where the dark spots are round and evenly dis-
tributed, and it is decreased by depigmenting formulations
such as azelaic acid and the soy extract, resulting in skin
lighting [3]. In addition, we examined the effect of topical
APPS on the conspicuous facial pores using another high-
resolution digital camera system called the Robo-skin ana-
lyser RSA-50® (Inforward Co, Tokyo, Japan) [1]. It was seen
that APPS treatment significantly decreased the conspicu-
ous and blackish pores but not the open pores after a
4-week treatment, indicating that APPS can decrease
conspicuous pores mainly by whitening them. Collectively,
the regression of conspicuous pores can be ascribed to the
suppression of perifollicular melanogenesis. Accordingly, to
investigate the mechanism of effect of fullerene, its effect
was examined on UVB-induced PGE2 production in
RhE because PGE2 reportedly stimulates tyrosinase
and dendricity of melanocytes [4,5]. Irradiation with
1000 mJ/cm2 increased PGE2 production in RhE by 62.3%
(p < 0.05, Mann-Whitney U-test). However, the addition of
28 μM fullerene significantly suppressed the UVB-induced
PGE2 production by 18.3% (p < 0.05) (Figure 2). Therefore,





of the conspicuous facial pores after fullerene treatment for 8 weeks.
n signed-rank test. (b) The photos of conspicuous pores on the cheek
el) and after fullerene treatment for 8 weeks (lower panel) are shown.
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Figure 2 Effect of fullerene on UVB-induced PGE2 production
in the reconstructed human epidermis. The reconstructed human
epidermis was incubated for 1 hour and then 2.8 μM or 28 μM
water-soluble polyvinylpyrrolidone (PVP)-wrapped fullerene or a
mock solution (1% PVP in PBS) was added. After incubation for
1 hour, the cultures were irradiated with 1000 mJ/cm2 UVB. Thirty
minutes later, the medium was refreshed and the cultures were
continued for 6 hours. Then the conditioned medium was subjected
to PGE2 ELISA. The graph shows the mean ± standard deviation
(n =7 ). *p < 0.05, Mann-Whitney U-test.
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on melanogenesis, which is associated with the pathogen-
esis of conspicuous pores. In addition, water-soluble
PVP-wrapped fullerene reportedly shows an appreciable
absorbance in the UVB spectrum (290–320nm) [6],
suggesting that the effect of fullerene on PGE2 may be
partially through UV absorption.
Here, we utilised the LabCyte EPI-MODEL24 but this
model does not contain melanocytes. Therefore, our assays
reflected only fullerene effect on epidermal keratinocytes.
On the other hand, fullerene has been previously reported
to inhibit UVA-induced melanogenesis from cultured hu-
man melanocytes [6]. Collectively, keratinocytes and mela-
nocytes both are suggested targets of fullerene. However, to
explore the effect of fullerene on PGE2 production more
precisely, it is of interest to study of animal models or even
ex-vivo human skin in the near future.Because even a dose of 80 mJ/cm2 UVB is reportedly
sufficient for induction of PGE2 production in cultured
human keratinocytes [7], the dose of UVB used for ir-
radiation in this study (1000 mJ/cm2) was extremely
high. Likewise, the mean of minimal erythema dose of
UVB for Japanese is 43.7 mJ/cm2 [8]; therefore, the UVB
dose utilised here is remarkably intense. However, previ-
ously it was reported that, whereas only 5 mJ/cm2 UVB
could stimulate co-culture of human keratinocytes and
melanocytes, a 100mJ/cm2 UVB dose was required to in-
duce melanogenesis in human pigmented reconstructed
epidermis. This indicates that the reconstructed epider-
mis is more resistant to the UVB effect than cultured
epidermal cells [9], supporting our observation of resist-
ance or insensitivity of the RhE to UVB.
In conclusion, the fullerene lotion significantly decreased
the conspicuous facial pores after an 8-week treatment.
Further, the experimental data suggests that the suppres-
sion of PGE2 production in epidermis is one of potential
pathways for this cosmetic effect of fullerene.
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